PDB Short entry for 1BXQ HEADER HYDROLASE 07-OCT-98 1BXQ TITLE ACID PROTEINASE (PENICILLOPEPSIN) COMPLEX WITH PHOSPHONATE INHIBITOR. CAVEAT 1BXQ MAN A 332 HAS WRONG CHIRALITY AT ATOM C4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (PENICILLOPEPSIN); COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.20 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PENICILLIUM JANTHINELLUM; SOURCE 3 ORGANISM_TAXID: 5079 KEYWDS HYDROLASE, PHOSPHONATE INHIBITORS EXPDTA X-RAY DIFFRACTION AUTHOR J.C.PARRISH,A.R.KHAN,M.E.FRASER,W.W.SMITH,P.A.BARTLETT,M.N.G.JAMES REVDAT 9 09-AUG-23 1BXQ 1 HETSYN REVDAT 8 29-JUL-20 1BXQ 1 CAVEAT COMPND REMARK HETNAM REVDAT 8 2 1 LINK SITE REVDAT 7 04-OCT-17 1BXQ 1 REMARK REVDAT 6 13-JUL-11 1BXQ 1 VERSN REVDAT 5 24-FEB-09 1BXQ 1 VERSN REVDAT 4 01-APR-03 1BXQ 1 JRNL REVDAT 3 16-JUN-00 1BXQ 1 DBREF REVDAT 2 22-DEC-99 1BXQ 4 HEADER COMPND REMARK JRNL REVDAT 2 2 4 ATOM SOURCE SEQRES REVDAT 1 14-OCT-98 1BXQ 0 JRNL AUTH A.R.KHAN,J.C.PARRISH,M.E.FRASER,W.W.SMITH,P.A.BARTLETT, JRNL AUTH 2 M.N.JAMES JRNL TITL LOWERING THE ENTROPIC BARRIER FOR BINDING CONFORMATIONALLY JRNL TITL 2 FLEXIBLE INHIBITORS TO ENZYMES. JRNL REF BIOCHEMISTRY V. 37 16839 1998 JRNL REFN ISSN 0006-2960 JRNL PMID 9836576 JRNL DOI 10.1021/BI9821364 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.W.SMITH,P.A.BARTLETT REMARK 1 TITL MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. 3. DESIGN, REMARK 1 TITL 2 SYNTHESIS, AND EVALUATION OF AN INHIBITOR BRIDGED BETWEEN P2 REMARK 1 TITL 3 AND P1' REMARK 1 REF J.AM.CHEM.SOC. V. 120 4622 1998 REMARK 1 REFN ISSN 0002-7863 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.DING,M.E.FRASER,J.H.MEYER,P.A.BARTLETT,M.N.G.JAMES REMARK 1 TITL MACROCYCLIC INHIBITORS OF PENICILLOPEPSIN. 2.X-RAY REMARK 1 TITL 2 CRYSTALLOGRAPHIC ANALYSES OF PENICILLOPEPSIN COMPLEXED WITH REMARK 1 TITL 3 A P3-P1 MACROCYCLIC PEPTIDYL INHIBITOR AND WITH ITS TWO REMARK 1 TITL 4 ACYCLIC ANALOGUES REMARK 1 REF J.AM.CHEM.SOC. V. 120 4610 1998 REMARK 1 REFN ISSN 0002-7863 REMARK 2 REMARK 2 RESOLUTION. 1.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 81.3 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.143 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.143 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.182 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 11.300 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4614 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 40991 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.136 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.136 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.175 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 11.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 4274 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 37815 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2366 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 97 REMARK 3 SOLVENT ATOMS : 405 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2861.7 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2279.3 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 10 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 11619 REMARK 3 NUMBER OF RESTRAINTS : 10360 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.059 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.064 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.031 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.049 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BXQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB. REMARK 100 THE DEPOSITION ID IS D_1000008145. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45997 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.440 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : 2.330 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 56.0350 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.31 REMARK 200 R MERGE FOR SHELL (I) : 0.09380 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 13.26 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1PPL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 18.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CH3COONA 35% SATD. AMMONIUM REMARK 280 SULPHATE PH 4.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 47.91450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.21550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 47.91450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.21550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 605 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 718 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 792 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR A 44 O - C - N ANGL. DEV. = -13.9 DEGREES REMARK 500 GLU A 45 C - N - CA ANGL. DEV. = 17.3 DEGREES REMARK 500 TYR A 198 CB - CG - CD2 ANGL. DEV. = 5.1 DEGREES REMARK 500 TYR A 198 CB - CG - CD1 ANGL. DEV. = -3.8 DEGREES REMARK 500 ASP A 313 CB - CG - OD1 ANGL. DEV. = 6.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 13 17.36 59.11 REMARK 500 SER A 281 56.13 -119.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CIC REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC RESIDUES DBREF 1BXQ A 1 323 UNP P00798 PENP_PENJA 1 323 SEQRES 1 A 323 ALA ALA SER GLY VAL ALA THR ASN THR PRO THR ALA ASN SEQRES 2 A 323 ASP GLU GLU TYR ILE THR PRO VAL THR ILE GLY GLY THR SEQRES 3 A 323 THR LEU ASN LEU ASN PHE ASP THR GLY SER ALA ASP LEU SEQRES 4 A 323 TRP VAL PHE SER THR GLU LEU PRO ALA SER GLN GLN SER SEQRES 5 A 323 GLY HIS SER VAL TYR ASN PRO SER ALA THR GLY LYS GLU SEQRES 6 A 323 LEU SER GLY TYR THR TRP SER ILE SER TYR GLY ASP GLY SEQRES 7 A 323 SER SER ALA SER GLY ASN VAL PHE THR ASP SER VAL THR SEQRES 8 A 323 VAL GLY GLY VAL THR ALA HIS GLY GLN ALA VAL GLN ALA SEQRES 9 A 323 ALA GLN GLN ILE SER ALA GLN PHE GLN GLN ASP THR ASN SEQRES 10 A 323 ASN ASP GLY LEU LEU GLY LEU ALA PHE SER SER ILE ASN SEQRES 11 A 323 THR VAL GLN PRO GLN SER GLN THR THR PHE PHE ASP THR SEQRES 12 A 323 VAL LYS SER SER LEU ALA GLN PRO LEU PHE ALA VAL ALA SEQRES 13 A 323 LEU LYS HIS GLN GLN PRO GLY VAL TYR ASP PHE GLY PHE SEQRES 14 A 323 ILE ASP SER SER LYS TYR THR GLY SER LEU THR TYR THR SEQRES 15 A 323 GLY VAL ASP ASN SER GLN GLY PHE TRP SER PHE ASN VAL SEQRES 16 A 323 ASP SER TYR THR ALA GLY SER GLN SER GLY ASP GLY PHE SEQRES 17 A 323 SER GLY ILE ALA ASP THR GLY THR THR LEU LEU LEU LEU SEQRES 18 A 323 ASP ASP SER VAL VAL SER GLN TYR TYR SER GLN VAL SER SEQRES 19 A 323 GLY ALA GLN GLN ASP SER ASN ALA GLY GLY TYR VAL PHE SEQRES 20 A 323 ASP CYS SER THR ASN LEU PRO ASP PHE SER VAL SER ILE SEQRES 21 A 323 SER GLY TYR THR ALA THR VAL PRO GLY SER LEU ILE ASN SEQRES 22 A 323 TYR GLY PRO SER GLY ASP GLY SER THR CYS LEU GLY GLY SEQRES 23 A 323 ILE GLN SER ASN SER GLY ILE GLY PHE SER ILE PHE GLY SEQRES 24 A 323 ASP ILE PHE LEU LYS SER GLN TYR VAL VAL PHE ASP SER SEQRES 25 A 323 ASP GLY PRO GLN LEU GLY PHE ALA PRO GLN ALA MODRES 1BXQ SER A 3 SER GLYCOSYLATION SITE MODRES 1BXQ THR A 7 THR GLYCOSYLATION SITE HET MAN A 331 11 HET MAN A 332 11 HET SO4 A 325 5 HET SO4 A 326 5 HET ACT A 330 4 HET PP8 A 324 43 HET GOL A 327 6 HET GOL A 328 6 HET GOL A 329 6 HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM SO4 SULFATE ION HETNAM ACT ACETATE ION HETNAM PP8 2-[(1R)-1-(N-(3-METHYLBUTANOYL)-L-VALYL-L-ASPARAGINYL)- HETNAM 2 PP8 AMINO)-3-METHYLBUTYL]HYDROXYPHOSPHINYLOXY]-3- HETNAM 3 PP8 PHENYLPROPANOIC ACID METHYLESTER HETNAM GOL GLYCEROL HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 MAN 2(C6 H12 O6) FORMUL 4 SO4 2(O4 S 2-) FORMUL 6 ACT C2 H3 O2 1- FORMUL 7 PP8 C29 H47 N4 O9 P FORMUL 8 GOL 3(C3 H8 O3) FORMUL 11 HOH *405(H2 O) HELIX 1 1 ALA A 12 ASP A 14 5 3 HELIX 2 2 ALA A 48 GLN A 51 1 4 HELIX 3 3 PRO A 59 THR A 62 1 4 HELIX 4 4 ALA A 110 GLN A 113 1 4 HELIX 5 5 SER A 127 ILE A 129 5 3 HELIX 6 6 PHE A 140 SER A 147 1 8 HELIX 7 7 SER A 172 LYS A 174 5 3 HELIX 8 8 ASP A 223 GLN A 232 1 10 HELIX 9 9 GLY A 269 ILE A 272 1 4 HELIX 10 10 ASP A 300 SER A 305 1 6 SHEET 1 A10 LEU A 39 VAL A 41 0 SHEET 2 A10 GLY A 120 GLY A 123 -1 N LEU A 121 O TRP A 40 SHEET 3 A10 THR A 26 ASP A 33 1 N ASN A 31 O LEU A 122 SHEET 4 A10 TYR A 17 ILE A 23 -1 N ILE A 23 O THR A 26 SHEET 5 A10 GLY A 4 PRO A 10 -1 N THR A 9 O ILE A 18 SHEET 6 A10 GLY A 163 PHE A 167 -1 N PHE A 167 O GLY A 4 SHEET 7 A10 LEU A 152 ALA A 156 -1 N ALA A 156 O VAL A 164 SHEET 8 A10 GLN A 306 ASP A 311 -1 N PHE A 310 O PHE A 153 SHEET 9 A10 GLN A 316 PRO A 321 -1 N ALA A 320 O TYR A 307 SHEET 10 A10 THR A 180 GLY A 183 -1 N THR A 182 O LEU A 317 SHEET 1 B 3 THR A 70 SER A 74 0 SHEET 2 B 3 SER A 80 ASP A 88 -1 N GLY A 83 O TRP A 71 SHEET 3 B 3 GLN A 100 ILE A 108 -1 N GLN A 107 O SER A 82 SHEET 1 C 2 VAL A 90 VAL A 92 0 SHEET 2 C 2 VAL A 95 ALA A 97 -1 N ALA A 97 O VAL A 90 SHEET 1 D 3 SER A 192 VAL A 195 0 SHEET 2 D 3 PHE A 208 ALA A 212 -1 N GLY A 210 O PHE A 193 SHEET 3 D 3 SER A 296 PHE A 298 1 N SER A 296 O ILE A 211 SHEET 1 E 4 GLN A 203 ASP A 206 0 SHEET 2 E 4 SER A 197 ALA A 200 -1 N ALA A 200 O GLN A 203 SHEET 3 E 4 PHE A 256 ILE A 260 -1 N SER A 259 O SER A 197 SHEET 4 E 4 TYR A 263 VAL A 267 -1 N VAL A 267 O PHE A 256 SHEET 1 F 2 LEU A 219 LEU A 221 0 SHEET 2 F 2 ILE A 287 SER A 289 1 N GLN A 288 O LEU A 219 SHEET 1 G 2 GLN A 237 ASP A 239 0 SHEET 2 G 2 GLY A 244 VAL A 246 -1 N VAL A 246 O GLN A 237 SHEET 1 H 2 ASN A 273 PRO A 276 0 SHEET 2 H 2 CYS A 283 GLY A 285 -1 N LEU A 284 O TYR A 274 SSBOND 1 CYS A 249 CYS A 283 1555 1555 2.04 LINK OG SER A 3 C1 MAN A 331 1555 1555 1.43 LINK OG1 THR A 7 C1 MAN A 332 1555 1555 1.41 CISPEP 1 GLN A 133 PRO A 134 0 -1.09 CISPEP 2 GLY A 314 PRO A 315 0 -4.25 SITE 1 CIC 2 ASP A 33 ASP A 213 CRYST1 95.829 46.431 65.186 90.00 115.39 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010435 0.000000 0.004953 0.00000 SCALE2 0.000000 0.021537 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016981 0.00000